Stockscreener 앱 받기
0.9908
4.19%
0.037
전일 마감가:
$0.9538
열려 있는:
$0.96
하루 거래량:
60,593
Relative Volume:
0.10
시가총액:
$99.08M
수익:
-
순이익/손실:
$-21.65M
주가수익비율:
-2.9834
EPS:
-0.3321
순현금흐름:
$-15.84M
1주 성능:
+0.07%
1개월 성능:
+6.93%
6개월 성능:
-28.50%
1년 성능:
-27.46%
1일 변동 폭
$0.955
$0.9969
1주일 범위
$0.94
$1.00
52주 변동 폭
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
명칭
Cardiol Therapeutics Inc
전화
-
주소
-
CRDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
0.9908 | 95.38M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
125.67 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.66 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.30 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-26 | 개시 | ROTH MKM | Buy |
| 2024-04-22 | 개시 | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
Movement Recap: Why Cardiol Therapeutics Inc stock could benefit from AI revolutionWeekly Risk Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Trading (CRDL) With Integrated Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol TherapeuticsFinancial Details - Crunchbase
(CRDL) Stock Trading Blueprint (CRDL:CA) - Stock Traders Daily
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
(CRDL) Financial Trading Report (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7%Here's Why - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% – Here’s Why - Defense World
Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Target Price at $8.00 - Defense World
CapEx per share of Cardiol Therapeutics Inc. – NASDAQ:CRDL - TradingView — Track All Markets
EBITDA per share of Cardiol Therapeutics Inc. – NASDAQ:CRDL - TradingView — Track All Markets
Why Cardiol Therapeutics Inc. stock attracts global investorsJuly 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Is Cardiol Therapeutics Inc. stock near bottom after declineJuly 2025 Update & Growth Focused Entry Reports - Улправда
Why Cardiol Therapeutics Inc. stock could benefit from AI revolution2025 Macro Impact & Weekly Breakout Opportunity Watchlist - DonanımHaber
How Cardiol Therapeutics Inc. stock reacts to job market dataTrade Performance Summary & Short-Term Trading Alerts - DonanımHaber
Why Cardiol Therapeutics Inc. stock is favored by top institutions2025 Performance Recap & Capital Efficiency Focused Ideas - DonanımHaber
Is Cardiol Therapeutics Inc. (CT9) stock a momentum leaderMarket Sentiment Report & AI Enhanced Trading Alerts - Улправда
How institutional buying supports Cardiol Therapeutics Inc. stockWeekly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
(CRDL) Investment Analysis (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 - TMX Newsfile
(CRDL) Proactive Strategies (CRDL:CA) - Stock Traders Daily
Moving Average Crossover Confirms Uptrend in Dhampur Sugar Mills LimitedStock Split Announcements & Identify Safe Investments - earlytimes.in
Investors in cash trouble should check out Cardiol Therapeutics Inc (CRDL) - setenews.com
Inflation Data: Will Cardiol Therapeutics Inc CT9 stock outperform small cap peersMarket Activity Report & Fast Entry Momentum Alerts - moha.gov.vn
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
Is Cardiol Therapeutics Inc. stock a defensive play in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - Newser
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease - MSN
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
How buyback programs support Cardiol Therapeutics Inc. (CT9) stockAnalyst Upgrade & Proven Capital Preservation Tips - Newser
Why institutional investors increase stakes in Cardiol Therapeutics Inc. (CT9) stock2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Should you sell your Cardiol Therapeutics stock? - Cantech Letter
Is Cardiol Therapeutics Inc. stock attractive for passive investorsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Will Cardiol Therapeutics Inc. (CT9) stock announce special dividendWeekly Profit Recap & Daily Volume Surge Signals - Newser
Will Cardiol Therapeutics Inc. (CT9) stock issue positive guidanceJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser
What hedge fund moves indicate for Cardiol Therapeutics Inc. (CT9) stockMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Cardiol Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
What RSI levels show for Cardiol Therapeutics Inc. (CT9) stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
Taking the lead: Cardiol Therapeutics Inc (CRDL) - setenews.com
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 14.6%Should You Sell? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 14.6%Should You Sell? - MarketBeat
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industryJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Cardiol Therapeutics (TSE:CRDL) Shares Down 14.6%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 13.9%What's Next? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 7.9%Here's Why - MarketBeat
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target - Investing.com Nigeria
Cardiol Therapeutics Inc (CRDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
1.70%
자본화:
|
볼륨(24시간):